Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jun 17 04:00PM ET
2.34
Dollar change
-0.10
Percentage change
-4.10
%
Index- P/E- EPS (ttm)-0.70 Insider Own55.44% Shs Outstand88.93M Perf Week-12.03%
Market Cap215.08M Forward P/E- EPS next Y-0.09 Insider Trans-5.88% Shs Float40.96M Perf Month-21.74%
Income-52.80M PEG- EPS next Q-0.09 Inst Own14.73% Short Float3.81% Perf Quarter182.71%
Sales403.15M P/S0.53 EPS this Y46.48% Inst Trans9.24% Short Ratio1.02 Perf Half Y917.39%
Book/sh0.06 P/B41.05 EPS next Y76.32% ROA-28.66% Short Interest1.56M Perf Year404.31%
Cash/sh0.43 P/C5.41 EPS next 5Y- ROE-227.77% 52W Range0.13 - 3.50 Perf YTD657.28%
Dividend Est.- P/FCF- EPS past 5Y-488.57% ROIC-52.51% 52W High-33.14% Beta0.16
Dividend TTM- Quick Ratio1.59 Sales past 5Y- Gross Margin13.07% 52W Low1767.52% ATR (14)0.30
Dividend Ex-Date- Current Ratio1.79 EPS Y/Y TTM13.86% Oper. Margin-12.91% RSI (14)39.30 Volatility2.94% 5.80%
Employees825 Debt/Eq20.18 Sales Y/Y TTM17.64% Profit Margin-13.10% Recom1.00 Target Price7.00
Option/ShortNo / Yes LT Debt/Eq18.83 EPS Q/Q4.88% Payout- Rel Volume0.99 Prev Close2.44
Sales Surprise- EPS Surprise- Sales Q/Q10.29% EarningsMay 14 AMC Avg Volume1.53M Price2.34
SMA20-18.22% SMA50-10.97% SMA200126.29% Trades Volume1,539,771 Change-4.10%
Date Action Analyst Rating Change Price Target Change
May-15-25Initiated BTIG Research Buy $7
Feb-26-24Resumed Jefferies Buy $2.50
Sep-14-22Initiated Guggenheim Buy $7
Aug-15-22Initiated Jefferies Buy $10
Jun-03-25 08:00AM
May-14-25 04:06PM
04:05PM
May-13-25 07:08PM
04:05PM
08:00AM Loading…
May-08-25 08:00AM
May-07-25 05:03PM
May-01-25 05:48PM
Apr-30-25 06:04AM
Apr-26-25 11:00AM
Apr-23-25 08:00AM
Apr-22-25 04:05PM
Apr-01-25 10:04AM
Mar-31-25 08:00AM
Mar-26-25 03:02AM
06:28PM Loading…
Mar-25-25 06:28PM
Mar-24-25 09:05AM
06:01AM
06:00AM
Mar-04-25 08:00AM
Feb-26-25 08:00AM
Dec-18-24 04:05PM
Nov-13-24 04:05PM
Nov-11-24 08:00AM
Nov-04-24 07:09PM
Oct-23-24 08:00AM
Oct-14-24 08:00AM
Sep-30-24 08:00AM
Sep-23-24 08:00AM
Aug-13-24 04:05PM
08:00AM Loading…
Jul-23-24 08:00AM
May-29-24 08:00AM
May-22-24 08:00AM
May-15-24 03:14AM
May-14-24 06:05PM
04:05PM
May-07-24 04:05PM
Apr-23-24 08:00AM
Apr-08-24 08:00AM
Apr-04-24 08:00AM
Apr-01-24 01:35PM
Mar-27-24 08:52PM
05:34PM
04:05PM
Mar-21-24 09:35AM
Mar-14-24 08:09AM
Mar-06-24 08:00AM
Feb-27-24 04:05PM
Feb-20-24 08:00AM
Jan-25-24 08:00AM
Dec-04-23 08:00AM
Nov-16-23 05:04AM
Nov-11-23 12:43PM
Nov-08-23 05:50PM
04:05PM
Oct-18-23 08:03AM
Oct-11-23 04:05PM
Sep-26-23 04:05PM
Sep-18-23 08:00AM
Aug-09-23 08:10AM
Aug-08-23 04:40PM
Aug-02-23 06:16AM
Jul-31-23 08:00AM
Jul-18-23 08:00AM
Jun-12-23 06:00AM
Jun-09-23 08:00AM
Jun-07-23 08:00AM
May-31-23 08:01AM
08:00AM
May-10-23 04:05PM
May-04-23 11:47AM
May-02-23 08:00AM
Apr-19-23 08:00AM
Mar-16-23 08:08PM
Mar-09-23 04:20PM
Feb-28-23 08:00AM
Feb-16-23 08:00AM
Dec-19-22 08:00AM
Dec-15-22 08:00AM
Nov-22-22 08:00AM
Nov-09-22 04:05PM
Nov-01-22 08:00AM
Oct-19-22 08:00AM
Oct-17-22 04:05PM
Oct-11-22 08:00AM
Oct-06-22 08:00AM
Sep-29-22 08:00AM
Sep-22-22 04:05PM
Sep-15-22 08:00AM
Sep-12-22 08:00AM
Aug-22-22 08:00AM
Aug-16-22 08:00AM
Aug-09-22 04:06PM
04:05PM
Jul-26-22 08:00AM
Jul-19-22 08:00AM
Jul-07-22 04:05PM
Jun-27-22 08:00AM
Jun-21-22 08:00AM
Jun-07-22 04:05PM
The Oncology Institute, Inc. provides cancer care treatment services. It operates through the following business segments: Dispensary, Patient Care, and Clinical Trials and Other. The company was founded in 2007 and is headquartered in Cerritos, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
M33 Growth I L.P.DirectorJun 05 '25Sale3.05673,6762,054,71213,950,557Jun 09 04:15 PM
M33 Growth I L.P.DirectorJun 05 '25Sale3.0576,324232,7881,272,724Jun 09 04:15 PM
Hively BradDirectorJun 03 '25Option Exercise0.901,867,6051,682,5242,579,638Jun 05 06:51 PM
Hively BradDirectorJun 03 '25Sale2.871,976,1375,672,106603,501Jun 05 06:51 PM
TOI M, LLC10% OwnerJun 05 '25Proposed Sale3.20127,207407,062Jun 05 06:17 PM
M33 Growth I L.P.10% OwnerJun 05 '25Proposed Sale3.201,122,7933,592,938Jun 05 06:13 PM
BRADFORD DANIEL HIVELYDirectorJun 03 '25Proposed Sale2.8739,600113,652Jun 03 05:08 PM
BRADFORD DANIEL HIVELYDirectorJun 03 '25Proposed Sale2.871,936,5375,557,861Jun 03 04:27 PM
M33 Growth I L.P.DirectorMay 20 '25Sale2.711,796,4684,873,63814,624,233May 22 07:38 PM
M33 Growth I L.P.DirectorMay 20 '25Sale2.71203,532552,1621,349,048May 22 07:38 PM
TOI M, LLC10% OwnerMay 20 '25Proposed Sale3.06203,532622,808May 20 06:25 PM
M33 Growth I L.P.10% OwnerMay 20 '25Proposed Sale3.061,796,4685,497,192May 20 06:19 PM
Virnich DanielChief Executive OfficerMar 26 '25Buy1.0422,64023,584724,363Mar 28 05:50 PM
Podnos YaleChief Medical OfficerMar 26 '25Buy1.049,0569,43479,049Mar 28 05:48 PM
Pacala Mark LDirectorMar 26 '25Buy1.0490,56294,338224,971Mar 28 05:41 PM
Johnson Karen MarieDirectorMar 26 '25Buy1.0436,22437,735203,409Mar 28 05:36 PM
Hively BradDirectorMar 26 '25Buy1.049,0569,434675,809Mar 28 05:34 PM
Castle JeremyChief Operating OfficerMar 26 '25Buy1.049,0569,43490,386Mar 28 05:33 PM
Carter Robert RossChief Financial OfficerMar 26 '25Buy1.049,0569,43439,407Mar 28 05:27 PM
BARASCH RICHARD ADirectorMar 26 '25Buy1.041,358,4481,415,0951,775,641Mar 28 05:25 PM
Hively BradDirectorNov 26 '24Buy0.17250,00042,500616,753Dec 02 04:04 PM
Hively BradDirectorDec 02 '24Buy0.1550,0007,500666,753Dec 02 04:04 PM